Delfina is a San Francisco-based maternal health company that pairs an AI-powered clinical platform with a consumer pregnancy app to make prenatal care proactive rather than reactive. Its predictive models flag rising risk - preterm birth, hypertensive disorders, gestational diabetes - while patients track vitals from home and connect around the clock with bilingual virtual doulas, dietitians, and mental health support. Founded in 2021 by physician-scientist Dr. Senan Ebrahim and his co-founders, Delfina sells to health plans, providers, and employers, and has raised roughly $22M to date, including a $17M Series A in January 2025.
Almond ObGyn is a Los Angeles-based, tech-enabled obstetrics and gynecology practice that set out to be the 'One Medical for women's health.' Founded in 2021 by Tara Raffi and Carly Allen and backed by a $7M seed round out of Y Combinator's S22 batch, Almond blended in-person clinic visits with telehealth, 24/7 text access to clinicians, and membership pricing to cover the full arc of reproductive care - from birth control and annual exams to PCOS, fertility, group pregnancy care, and menopause.
Bloom Care is a Brazilian femtech building the country's largest virtual clinic for women's and family health. Founded in 2017 by three women, its app pairs members with gynecologists, obstetricians, pediatricians, psychologists and nutritionists for continuous, evidence-based care across the full life journey - from menstrual health and fertility through pregnancy, postpartum, parenting and menopause. Sold mostly through employers and health plans on a B2B2C model, Bloom counts partners like Sanofi, SulAmérica, Natura and Nestlé, and was named to CB Insights' Digital Health 150.